Violation Tracker Individual Record
Company:
InterMune Inc.
Current Parent Company:
Roche
Penalty:
$36,900,000
Year:
2006
Date:
October 26, 2006
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Violation Description:
InterMune, Inc, a Brisbane, Cal., biopharmaceutical company, agreed to pay the United States more than $36.9 million to resolve criminal charges and civil liabilities in connection with its alleged illegal promotion and marketing of Actimmune.
Level of Government:
federal
Action Type:
agency action
Agency:
Justice Department Civil Division
Civil or Criminal Case:
civil and criminal
Prosecution Agreement:
deferred prosecution agreement
HQ Country of Parent:
Switzerland
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
